Form EFFECT Telomir Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 28, 2025 9:00 A.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- StopOverpaying.org Surpasses 2 Million Users, Marking Major Milestone for Car Insurance Comparison Platform
- Consumer Trust in AI Is on Track to Grow by 15 Percentage Points by 2030
- Silver Palace Nominated for gamescom Best Mobile Game Award as New Trailer Debuts at Opening Night Live
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
